Coronavirus research cannot wait.
As we know researchers around the world are diligently working to gain a better understanding of the novel coronavirus with the goal of rapidly identifying future treatment options and possible vaccine targets. With a comprehensive portfolio of genetic analysis products, Thermo Fisher Scientific is your trusted partner for virus discovery, pathogen detection, epidemiological surveillance, vaccine development, and host genetics to advance your research.
This is the second part of the genetics analysis solutions presentation focusing on vaccine research as well as host genetics and population genomics studies. This talk will explain why immune repertoire Sequencing with NGS is not only an important tool for vaccine development but also can be utilized to predict disease severity. This presentation will provide case studies example of microarray genotyping is used to identify vulnerable population as well as to study host genetic factors associated with potential risk and susceptibility to SARS-CoV-2.